GGrantIndex
Sort

8,912 grants matching sars cov 2

Structure and Mechanism of Programmed Ribosomal Frameshifting in SARS coronavirus

$380,250
Victoria Manuel D'souza · Harvard University · R01 · FY2015 · AI

Structure and Mechanism of Programmed Ribosomal Frameshifting in SARS coronavirus

$380,250
Victoria Manuel D'souza · Harvard University · R01 · FY2016 · AI

Structure and Mechanism of Programmed Ribosomal Frameshifting in SARS coronavirus

$380,250
Victoria Manuel D'souza · Harvard University · R01 · FY2014 · AI

Core B: Shared Resource Core For Characterizing Antibody Responses To SARS-CoV-2 And Other Pathogenic Human Coronaviruses

$380,115
Aravinda M De Silva · Univ Of North Carolina Chapel Hill · U54 · FY2022 · CA

Advancing Psychosocial and Biobehavioral Stress Measurement to Understanding Aging

$380,082
Elissa S. Epel · University Of California, San Francisco · R24 · FY2022 · AG

Four-dimensional Adhesion Frequency Assay for Full Profiling of Receptor-ligand Interactions on Cells

$379,953
Yuebing Zheng · University Of Texas At Austin · R01 · FY2023 · GM

Four-dimensional Adhesion Frequency Assay for Full Profiling of Receptor-ligand Interactions on Cells

$379,952
Yuebing Zheng · University Of Texas At Austin · R01 · FY2022 · GM

Predictive Modeling of COVID-19 Progression in Older Patients

$379,884
S Michal Jazwinski · Tulane University Of Louisiana · P20 · FY2020 · GM

NBER Center for Aging and Health Research-Post COVID-19 Experiences Among Adults with ADRD

$379,302
Anne Case · National Bureau Of Economic Research · P30 · FY2023 · AG

Aerosol Biology Small Animal Models

$379,121
R Mark Buller · Washington University · U54 · FY2011 · AI

UC San Diego Raising Advancement and Parity for Infectious Disease Researchers (RAPID) Faculty Development Program

$379,080
Joann Trejo · University Of California, San Diego · R25 · FY2025 · AI

Development of peptide-based vaccine against SARS-CoV

$379,068
Gang Liu · Institute Of Materia Medica · U01 · FY2006 · AI

Systems biological assessment of T cell responses to vaccination

$379,046
Mark M Davis · Stanford University · U19 · FY2023 · AI

Immune Responses to Malaria, HIV and SARS-CoV-2 Infection and Immunization- Data Management and Analysis Core

$379,016
Raphael Gottardo · Seattle Children'S Hospital · U19 · FY2022 · AI

Characterization of the SARS-CoV frameshift signal

$378,969
Jonathan D. Dinman · Univ Of Maryland, College Park · R01 · FY2008 · AI

Characterization of the SARSCoV frameshift signal

$378,969
Jonathan D. Dinman · Univ Of Maryland, College Park · R01 · FY2009 · AI

Mechanistic Characterization of the IBD Risk Gene, PTPN2, as a Novel Susceptibility Marker for Increased SARS-CoV-2 Infection

$378,939
Declan McCole · University Of California Riverside · R01 · FY2021 · DK

Temple University Gastroparesis Clinical Center

$378,877
Henry P. Parkman · Temple Univ Of The Commonwealth · U01 · FY2024 · DK

SIRPgamma: a novel checkpoint regulator of effector responses from human T-cells

$378,837
Sushmita Sinha · Texas Woman'S University · R15 · FY2023 · AI

Structures and Dynamics of Proton- and Cation-Conducting Viroporins

$378,680
Mei Hong · Massachusetts Institute Of Technology · R01 · FY2025 · GM

Mechanistic Characterization of the IBD Risk Gene, PTPN2, as a Novel Susceptibility Marker for Increased SARS-CoV-2 Infection

$378,549
Declan McCole · University Of California Riverside · R01 · FY2022 · DK

Discovery-Driven Mathematics and Artificial Intelligence for Biosciences and Drug Discovery

$378,505
Guowei Wei · Michigan State University · R35 · FY2023 · GM

Mechanistic Characterization of the IBD Risk Gene, PTPN2, as a Novel Susceptibility Marker for Increased SARS-CoV-2 Infection

$378,139
Declan McCole · University Of California Riverside · R01 · FY2023 · DK

Discovery-Driven Mathematics and Artificial Intelligence for Biosciences and Drug Discovery

$377,995
Guowei Wei · Michigan State University · R35 · FY2024 · GM

FeverPhone: Point of Care Diagnosis of Acute Febrile Illness using a Mobile Device

$377,992
David Erickson · Cornell University · R01 · FY2020 · EB